134 related articles for article (PubMed ID: 31996767)
1. Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia.
Huet S; Bouvard A; Ferrant E; Mosnier I; Chabane K; Salles G; Michallet AS; Hayette S; Sujobert P
Leukemia; 2020 Aug; 34(8):2257-2259. PubMed ID: 31996767
[No Abstract] [Full Text] [Related]
2. Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.
Delgado J; Salaverria I; Baumann T; Martínez-Trillos A; Lee E; Jiménez L; Navarro A; Royo C; Santacruz R; López C; Payer AR; Colado E; González M; Armengol L; Colomer D; Pinyol M; Villamor N; Aymerich M; Carrió A; Costa D; Clot G; Giné E; López-Guillermo A; Campo E; Beà S
Haematologica; 2014 Nov; 99(11):e231-4. PubMed ID: 24997154
[No Abstract] [Full Text] [Related]
3. Bi-clonal disease in patients with chronic lymphocytic leukaemia as detected by analysing IGHV mutation status.
Sheikholeslami MR; Ma W; Uyeji J; Tornyos K; Cone L; Mamus S; Albitar M
Br J Haematol; 2007 Nov; 139(3):507-9. PubMed ID: 17868045
[No Abstract] [Full Text] [Related]
4. ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia.
Ghia P; Stamatopoulos K; Belessi C; Moreno C; Stilgenbauer S; Stevenson F; Davi F; Rosenquist R;
Leukemia; 2007 Jan; 21(1):1-3. PubMed ID: 17167526
[No Abstract] [Full Text] [Related]
5. Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemia.
Sandoval-Sus JD; Chavez JC; Dalia S; Naqvi SMH; Talati C; Nodzon L; Kharfan-Dabaja MA; Pinilla-Ibarz J
Leuk Lymphoma; 2018 Jan; 59(1):59-68. PubMed ID: 28641468
[TBL] [Abstract][Full Text] [Related]
6. Another step forward in the 20-year history of
Giudice ID; Foà R
Haematologica; 2019 Feb; 104(2):219-221. PubMed ID: 30705114
[No Abstract] [Full Text] [Related]
7. A biclonal case of chronic lymphocytic leukaemia with discordant mutational status of the immunoglobulin heavy chain variable region and bimodal CD49d expression.
Hotinski AK; Best OG; Thurgood LA; Lower KM; Kuss BJ
Br J Haematol; 2021 Feb; 192(3):e77-e81. PubMed ID: 33278845
[No Abstract] [Full Text] [Related]
8. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
[TBL] [Abstract][Full Text] [Related]
9. Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia.
Rodríguez CM; Stanganelli C; Bussi C; Arroyo D; Sastre D; Heller V; Iribarren P; Slavutsky I
Leuk Lymphoma; 2018 May; 59(5):1239-1243. PubMed ID: 28868956
[No Abstract] [Full Text] [Related]
10. Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B cells.
Ghiotto F; Marcatili P; Tenca C; Calevo MG; Yan XJ; Albesiano E; Bagnara D; Colombo M; Cutrona G; Chu CC; Morabito F; Bruno S; Ferrarini M; Tramontano A; Fais F; Chiorazzi N
Mol Med; 2011; 17(11-12):1188-95. PubMed ID: 21785810
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments.
Visentin A; Facco M; Gurrieri C; Pagnin E; Martini V; Imbergamo S; Frezzato F; Trimarco V; Severin F; Raggi F; Scomazzon E; Pravato S; Piazza F; Semenzato G; Trentin L
Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):678-685.e4. PubMed ID: 31371221
[TBL] [Abstract][Full Text] [Related]
12. COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.
Plesingerova H; Librova Z; Plevova K; Libra A; Tichy B; Skuhrova Francova H; Vrbacky F; Smolej L; Mayer J; Bryja V; Doubek M; Pospisilova S
Leuk Lymphoma; 2017 Jan; 58(1):70-79. PubMed ID: 27185377
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin heavy variable somatic hyper mutation status in chronic lymphocytic leukaemia: on the threshold of a new era?
Langerak AW; Davi F; Stamatopoulos K
Br J Haematol; 2020 Jun; 189(5):809-810. PubMed ID: 32002980
[No Abstract] [Full Text] [Related]
14. Change in IgHV Mutational Status of CLL Suggests Origin From Multiple Clones.
Osman A; Gocke CD; Gladstone DE
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):97-99. PubMed ID: 28041846
[TBL] [Abstract][Full Text] [Related]
15. 98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia.
Shi K; Sun Q; Qiao C; Zhu H; Wang L; Wu J; Wang L; Fu J; Young KH; Fan L; Xia Y; Xu W; Li J
Cancer Med; 2020 Feb; 9(3):999-1007. PubMed ID: 31849198
[TBL] [Abstract][Full Text] [Related]
16. Searching for surrogates for IGHV mutations in chronic lymphocytic leukemia.
Hamblin TJ
Leuk Res; 2011 Nov; 35(11):1432-5. PubMed ID: 21840049
[TBL] [Abstract][Full Text] [Related]
17. Reliable IGHV status assessment by next generation sequencing in routine practice for chronic lymphocytic leukemia.
Boulland ML; Vic S; Thonier F; Ganard M; Lamy T; Fest T; Guibert S; Pastoret C
Leuk Lymphoma; 2021 Nov; 62(11):2800-2803. PubMed ID: 34060965
[No Abstract] [Full Text] [Related]
18. Mutational status of Ig V(H) genes provides clinically valuable information in B-cell chronic lymphocytic leukemia.
Naylor M; Capra JD
Blood; 1999 Sep; 94(6):1837-9. PubMed ID: 10477711
[No Abstract] [Full Text] [Related]
19. Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases.
Morabito F; Shanafelt TD; Gentile M; Reda G; Mauro FR; Rossi D; Di Renzo N; Molica S; Angrilli F; Chiarenza A; Cutrona G; Chaffee KG; Parikh SA; Tripepi G; D'Arrigo G; Vigna E; Recchia AG; Cortelezzi A; Gaidano G; Di Raimondo F; Fais F; Foà R; Neri A; Ferrarini M
Am J Hematol; 2018 Sep; 93(9):E216-E219. PubMed ID: 29984867
[No Abstract] [Full Text] [Related]
20. Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia.
Visco C; Moretta F; Falisi E; Facco M; Maura F; Novella E; Nichele I; Finotto S; Giaretta I; Ave E; Perbellini O; Guercini N; Scupoli MT; Trentin L; Trimarco V; Neri A; Semenzato G; Rodeghiero F; Pizzolo G; Ambrosetti A
Am J Hematol; 2013 Apr; 88(4):277-82. PubMed ID: 23450508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
